Plus: Binance has suffered the biggest crypto hack in history.

This is today's edition of The Download , our weekday newsletter that provides a daily dose of what's going on in the world of technology.

Eating disorders are on the rise. GLP-1s could make things worse.

GLP-1 weight-loss drugs are one of the biggest biotech breakthroughs of the last decade. But to some clinicians, they can represent something sinister—a potential trigger for eating disorders.

A new report suggests the global incidence of anorexia nervosa and bulimia nervosa shot up by 71% between 1990 and 2023. And clinicians are already seeing GLP-1s exacerbate the issue.

Here’s how they could make an already growing problem worse .

—Jessica Hamzelou

This story is from The Checkup, our weekly biotech newsletter.…